Evidence map›Paper›PMID 25725933›Full record

ArticleDrug and alcohol dependence2015

Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.

Leslie H Lundahl, Mark K Greenwald

Open access · greenAbstract readControlled Clinical Trial
In one paragraph

Article in Drug and alcohol dependence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Artificial Intelligence Approximates Human Affect Ratings of Cannabis Images.medRxiv : the preprint server for health sciences · 2025
    Article
  3. Article
  4. The role of sex in the association between cannabis use disorder and resting-state functional connectivity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Article
  6. Article
  7. The importance of psychology for shaping legal cannabis regulation.Experimental and clinical psychopharmacology · 2021
    Review
  8. Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2021
    Article
  9. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Leslie H LundahlDepartment of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, Detroit, MI, USA. Electronic address: llundahl@med.wayne.edu.
Mark K GreenwaldDepartment of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, Detroit, MI, USA; Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.
Wayne State University · US

Funding

Smoked Marijuana Discrimination and Marijuana Choice in Humans: A Laboratory ModeR01DA026761 · NIDA · WAYNE STATE UNIVERSITY · PI LUNDAHL, LESLIE H · 2009 to 2010
$686k
Cue Reactivity Model/Pharm. Intervention in Cannabis UseR21DA019236 · NIDA · WAYNE STATE UNIVERSITY · PI LUNDAHL, LESLIE H · 2004 to 2005
$400k
NIDA NIH HHS R01 DA026761NIDA NIH HHS R21 DA019236NIDA NIH HHS R21DA019236
6 · The paper itself

Abstract

backgroundThe current study tested whether oral Δ(9)-tetrahydrocannabinol (THC: 0-, 10-, and 20-mg) pretreatment would attenuate polysensory cue-induced craving for marijuana.

methodsCannabis dependent participants (7 males and 7 females, who smoked on average 5.4 ± 1.1 blunts daily) completed 3 experimental sessions (oral THC pretreatment dose; counterbalanced order) using a placebo-controlled within-subject crossover design. During each session, participants completed a baseline evaluation and were first exposed to neutral cues then marijuana cues while physiological measures and subjective ratings of mood, craving, and drug effect were recorded.

resultsFollowing placebo oral THC pretreatment, marijuana (vs. neutral) cues significantly increased ratings of marijuana craving (desire and urge to use, Marijuana Craving Questionnaire (MCQ)-Compulsivity scale), anxious mood and feeling hungry. Males also reported feeling more "Down" during marijuana cues relative to females. Pretreatment with oral THC (10-mg and/or 20-mg vs. placebo) significantly attenuated marijuana cue-induced increases in craving and anxiety but not hunger. Oral THC attenuation of the cue-induced increase in MCQ-Compulsivity ratings was observed in females only. Oral THC produced statistically (but not clinically) significant increases in heart rate and decreases in diastolic blood pressure, independent of cues.

conclusionsThese marijuana-cue findings replicate earlier results and further demonstrate that oral THC can attenuate selected effects during marijuana multi-cue exposure, and that some of these effects may be sex-related. Results of this study suggest oral THC may be effective for reducing marijuana cue-elicited (conditioned) effects. Further study is needed to determine whether females may selectively benefit from oral THC for this purpose.

Indexed as

CuesAdministration, OralAdolescentAdultAffectAnxietyBlood PressureCannabinoid Receptor AgonistsCravingCross-Over StudiesDose-Response Relationship, DrugDronabinolFemaleHeart RateHumansMaleCannabinoid Receptor AgonistsDronabinolCannabis dependenceCravingCuesDronabinolMarijuanaTHC

Identifiers

PMID25725933
PMCPMC10369174
OpenAlexW1984381012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.